CollPlant Biotechnologies Ltd

NAS:CLGNHealthcarenasdaq_composite

$3.62+0.00%LiveIn session · ≈ AED 13.29 · Market cap $6.84M · Next earnings Wed 2 Dec

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	43.7%	87.2%	−393.6%	71.8%	−417.1%	26.3%	—	—
Operating margin	−91.2%	0.4%	−5,718.1%	−68.5%	−3,349.7%	−484.3%	−484.3%	+0.0 pts
Net margin	−94.1%	1.5%	−5,660.5%	−64.0%	−3,225.0%	−484.6%	−484.6%	+0.0 pts
EBITDA margin	−82.8%	6.7%	−5,289.3%	−53.9%	−3,020.2%	−445.5%	—	—
Return on equity	−129.0%	0.5%	−52.4%	−24.8%	−123.3%	−188.9%	−188.9%	+0.0 pts
Return on assets	−53.3%	0.5%	−44.8%	−20.6%	−88.8%	−106.5%	−106.5%	+0.0 pts
Return on capital employed	−75.1%	0.1%	−49.3%	−24.3%	−109.6%	−141.5%	—	—
Debt / equity	0.8×	0.1×	0.1×	0.1×	0.2×	0.5×	0.5×	+0.0%
Debt / assets	31.3%	7.0%	7.7%	9.3%	16.5%	26.4%	—	—
Interest coverage	−164.7×	1.8×	−502.9×	−751.2×	−1,014.8×	−765.5×	—	—
Current ratio	1.7×	15.0×	10.2×	8.6×	4.4×	2.5×	2.5×	+0.0%
Quick ratio	1.3×	14.6×	9.7×	8.4×	4.3×	2.3×	—	—
Cash ratio	1.0×	4.4×	9.6×	8.2×	4.0×	2.2×	2.2×	+0.0%
Asset turnover	0.6×	0.3×	0.0×	0.3×	0.0×	0.2×	—	—
Inventory turnover	2.7×	1.9×	1.0×	4.3×	6.1×	3.0×	—	—
Receivables turnover	7.4×	57.9×	33.2×	27.9×	0.9×	2,371.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.